Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, is thrilled to announce a collaboration with Roche, the world’s largest biotechnology company and the global leader in in-vitro diagnostics.
In a new study, researchers at Institut Universitaire du Cancer-Oncopole and Université Toulouse III-Paul Sabatier in Toulouse, France, developed methods for hematoxylin and eosin (H&E) color augmentation and image normalization to reduce bias caused by stain color variations in histopathology images used for machine learning.
Join us as we dive into the world of digital pathology and explore how the revolutionary TWOD system is transforming the workflow for pathologists.
At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, shared new details about its upcoming product roadmap and its ongoing strategy to democratize access to single cell analysis.
HistoWiz, a leading provider of histopathology services, is proud to announce the launch of its innovative FFPE Block Management Solution, an integrated feature of the recently upgraded PathologyMap™ 2.0 platform. This new solution provides researchers with unparalleled access and control over their valuable tissue samples, combining digital convenience with physical security.
Clario, a leading provider of endpoint data solutions to the clinical trials industry, is excited to announce a strategic partnership with PathAI, a leader in AI-powered digital pathology solutions aimed at improving diagnostic accuracy and efficiency. This collaboration offers a single-vendor solution for efficient anatomical pathology services and next-generation video endoscopy analysis.
In Germany, there are currently around 8,500 people on the waiting list for a donor organ, the majority of whom are waiting for a kidney. Despite a positive attitude among the population towards donation, the organ shortage remains an urgent problem, which is exacerbated by long waiting times and the increasing burden on the healthcare system. Why is it that only one in ten people on the waiting list actually receives a donor organ? One crucial factor could be the use of outdated methods to assess organ quality. However, new studies show that switching to technologies such as the VivaScope 2500 could revolutionize this process. The digitalization of transplant pathology promises not only faster and more precise diagnoses, but also a relief of the healthcare system – a significant step towards improving patient care and increasing the number of transplants.
Over 100,000 individuals globally are living with cystic fibrosis (1). Most are diagnosed by age 2. While scientists have identified the rare cell population that plays a key role in cystic fibrosis biology, there’s still a lot to learn about the underlying developmental errors and local cellular relationships that may give rise to or exacerbate this life-changing disease.
Join us for this 1-hour webinar to learn about HALO AP platforms with regulatory clearances supporting diagnostic workflows in the US (FDA cleared HALO AP Dx) and in the EU and UK (CE-IVDR marked HALO AP®).
The National Pathology Imaging Co-operative (NPIC) at Leeds Teaching Hospitals NHS Trust will receive £5.1 million from the Government to improve data infrastructure that will aid cancer and disease research – potentially leading to faster and more accurate diagnosis of cancer and other diseases.
